Juan D. Cañete

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

Laure Gossec, Josef S Smolen, Sofía Ramiro et al. · Annals of the Rheumatic Diseases · 2016 · 913 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

Laure Gossec, Josef S Smolen, C. Gaujoux-Viala et al. · Annals of the Rheumatic Diseases · 2011 · 447 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

Laure Gossec, Maarten de Wit, Uta Kiltz et al. · Annals of the Rheumatic Diseases · 2014 · 421 citations · Full text

Medicine, Clinical Sciences, Health Assessment +16

SERUM CYTOKINES (IL-6, TNF-α, IL-1β AND IFN-γ) IN ANKYLOSING SPONDYLITIS: A CLOSE CORRELATION BETWEEN SERUM IL-6 AND DISEASE ACTIVITY AND SEVERITY

Jordi Gratacós, A. Collado, Xavier Filella et al. · Lara D. Veeken · 1994 · 336 citations

Medicine, Immunology, Immunopathology +8

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Frances Humby, Patrick Durez, Maya H Buch et al. · The Lancet · 2021 · 315 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17